Objective: To gain insight into the mechanisms underlying KCNQ2 encephalopathy by examining the electrophysiologic properties of mutant Kv7.2 channels in different multimeric configurations. Methods: We analyzed the genotype-phenotype relationship in 4 patients with KCNQ2 encephalopathy and performed electrophysiologic analysis of M-currents mediated by homomeric Kv7.2 or heteromeric Kv7.2/Kv7.3 channels. Results: Negligible or no current was recorded in cells expressing homomeric E130K, W270R, or G281R de novo mutants, and it was reduced by more than 90% for the L243F maternally inherited mutant. The E130K and G281R mutants presented a marked dominant-negative behavior, whereas the current density was partially reduced (L243F) or not affected (W270R) when coexpressed with wildtype Kv7.2 subunits. In contrast, the extent of Kv7.3 "rescue," which yields negligible currents on its own, followed the sequence E130K > L243F > W270R, whereas no rescue was observed with the G281R mutant. No significant effects on current density were observed when subunits were expressed in a 0.5:0.5:1.0 (Kv7.2:mutant:Kv7.3) DNA ratio to mimic the genetic balance. There was an increase in sensitivity to phosphatidylinositol 4,5-bisphosphate (PIP 2 ) depletion for W270R/Kv7.3, but no substantial differences were observed when the mutated subunits were coexpressed with Kv7.2 or both Kv7.2 and Kv7.3. Significance: There was a marked disparity of the impact of these mutations on Kv7.2 function, which varied on association with Kv7.2 or Kv7.3 subunits. Current density of homomeric channels was the most reliable property relating Kv7.2 function to encephalopathy, but other factors are required to explain the milder phenotype for some individuals carrying the maternally inherited L243F mutation.
| INTRODUCTION
Kv7 channels are slow activating and noninactivating voltage-gated potassium channels expressed in several neuronal populations. Kv7.2 and Kv7.3 are expressed in the central and peripheral nervous system 1 as homo-and heterotetramers, yielding the neuronal M-current, a key controller of neuronal excitability. 2, 3 The name of this current relates to its inhibition by activation of muscarinic receptors, which proceed by depleting phosphatidylinositol 4,5-bisphosphate (PIP 2 ) from the plasma membrane. Mutations in KCNQ2, along with the less common KCNQ3, were reported as the cause of autosomal dominant benign neonatal seizures (BFNS), mainly by haploinsufficiency. 4, 5 Although BFNS usually bears an excellent longterm prognosis, seizure recurrences later in life have also been described. 6 More recently, it was found that de novo mutations in KCNQ2 are responsible for 5%-23% of early infantile epileptic encephalopathies (EIEEs). [7] [8] [9] [10] [11] encephalopathy often presents in the first week of life with a distinct electroclinical pattern characterized by intractable and prominent tonic seizures, with or without autonomic features, and burst-suppression or multifocal epileptiform abnormalities with attenuation on electroencephalography (EEG). Neuroimaging reveals frontal lobe hypoplasia or transient abnormalities of the basal ganglia or thalamus in some cases. The neurodevelopmental outcome is poor in all children, even if seizure control is achieved in the initial months of life. 12 It has been proposed that the clinical variability of the KCNQ2-related epilepsy could be associated with the functional consequence of mutations on M-current and could thus be predictive of the neurologic prognosis. 13, 14 Herein we describe the electrophysiologic consequences of 4 mutations found in patients with EIEE. The impact of these mutations depended on the configuration (homomeric, heteromeric) and was diverse, having all in common an impairment of function in Kv7.2 homomeric configuration. Based on our results, we discuss the potential role of homomeric Kv7.2 channels for the inhibition-excitation equilibrium during a critical developmental window.
| PATIENTS AND METHODS

| Clinical summary
Among a cohort of 78 EIEE cases including patients from 4 Spanish third-level health centers, 4 patients diagnosed with neonatal onset epileptic encephalopathy, carrying heterozygous KCNQ2 mutations, were selected for this study. Patients 1 to 3 are Spanish, and Patient 4 is Moroccan. All infants had extensive infectious, metabolic, and neuroimaging investigations that excluded other causes of their encephalopathy. Written informed consent for participation was obtained from the patient's parents/guardians. Patients were followed at Hospital Universitari Vall d'Hebron, Barcelona (Patients 1, 2, and 4) and Hospital Reina Sofia, Córdoba (Patient 3). All EEG recordings were reviewed directly by an expert neurophysiologist and epileptologist. Local Institutional Review Boards at both centers approved the study following the Declaration of Helsinki.
| Genetic analysis
The pedigree of each family was ascertained by parental history. DNA was extracted from peripheral blood of probands and their parents following standard methods.
Patient 1 was referred for diagnostic genetic testing using a next-generation sequencing panel enriched with 84 epilepsy-related genes. Enrichment and hybridization were performed with custom Sure Select XT kit (Agilent) and MiSeq machine (Illumina) was used to sequence the final library (Centro Nacional de Genotipado, Santiago de Compostela, Spain).
Based on family history, Patient 2 had a targeted investigation of KCNQ2 and KCNQ3 by polymerase chain reaction (PCR) and Sanger sequencing. Because of his atypical dysmorphic features, comparative genomic hybridization array (aCGH) and a further whole exome sequencing (WES) analysis were also performed.
Samples of Patient 2 and trios from Patients 3 and 4 underwent whole-exome sequencing. Exome capture and enrichment were performed using NimbleGen SeqCap EZ Exome v3.0 and Illumina TruSeq kits. Libraries were sequenced at 30X coverage in a HiSeq 2000 instrument. Each trio of exomes was aligned to a NCBI build 37 reference sequence. Variants were jointly called with GATK Haplotype Caller, annotated using SnpEff and VarAnnot, and classified according to its predicted functional effect. The first stage of analysis consisted of inspecting any de novo variants in genes previously associated with EIEE. The putative pathogenic variants were validated using direct Sanger sequencing.
KEY POINT
• There was a marked disparity on the functional impact of mutation, which varied on association with Kv7.2 or Kv7.3 subunits • The most reliable property relating Kv7.2 function to encephalopathy was current density of homomeric channels • Homomeric Kv7.2 channel activity during embryonic or neonatal development may be critical for the severity of KCNQ2 encephalopathy
| Electrophysiologic measurements
The human isoform 3 Kv7.2 (Y15065) and Kv7.3 (NM004519) complementary DNAs were used in this study. Whole-cell patch recordings of HEK293T cells were obtained as described previously. 15 Our protocol to study the sensitivity to danio rerio variant of the voltage-sensing phosphatase (DrVSP) activation is similar to that used by Hille and collaborators. 16 DrVSP was activated by a 200 msec jump to +100 mV, and the voltage was returned to the holding potential of −20 mV. The size of the outward relaxation before and after the +100 mV jump was used to estimate the effect of DrVSP activation on M-current size. 17, 18 Pipettes were filled with an internal solution containing (mmol/L): 125 KCl, 10 HEPES (K), 5 MgCl 2 , 5 EGTA, and 5 Na 2 ATP, adjusted to pH 7.2 with KOH and the osmolarity adjusted tõ 300 mOsm with mannitol. The amplitude of the Kv7 current was defined as the peak difference in current relaxation measured at −30 mV after 500-1500 msec pulses to −110 mV (all channels closed) and to +20/+10 mV (all channels opened). Currents values at the beginning of the −30 mV (tail currents) pulse were measured, normalized, and fitted to a Boltzmann distribution
)/S) ) to obtain V 1/2 and slope factor k. Data are shown as the mean ± standard error of the mean (SEM). The differences between the means were evaluated using the unpaired Student's t test, where values of P ≤ 0.05 were considered statistically significant. The number of cells in each experiment is indicated in brackets in the figures. The results are from 2 or more independent batches of cells. In all figures, *, **, and *** indicate significance at P < 0.05, P < 0.01, and P < 0.001, respectively.
| RESULTS
| Clinical Features
The 4 patients ( Figure 1 ) presented a KCNQ2 encephalopathy phenotype (for a detailed account of clinical features see Table 1 ). Figure 1B shows the localization of the different mutations on the structure of the homologous Kv7.1 subunit, 19 and the multiple alignments shown in Figure 1C reveal that the mutated residues are conserved across all Kv7 isoforms. 2) indicating the localization of different mutations associated with EIEE (red-filled amino acids). The gray box indicates the membrane region. C, Multiple sequence alignment of sequences adjacent to the mutated residues illustrates the paralog conservation of Glu130, Leu243, Trp270, and Gly281 mutated in the 4 patients described here among different KCNQs association with retigabine-induced neurogenic bladder (retigabine dosing: 20 mg/kg/day).
Neuroimaging abnormalities were present in 3 cases, including thin corpus callosum, delayed myelination, transient T2-weighted image and fluid-attenuated inversion recovery (FLAIR) lentiform nuclei hyperintensities and moderate bilateral frontal atrophy ( Figure S1 ). Although seizures were relatively well controlled, moderate to profound intellectual disability was found in all, with some degree of motor impairment. Autism spectrum disorder was noted in all surviving patients. Also, 2 of them had some dysmorphic features and 3 had nystagmus. Progressive microcephaly was observed in only Patient 3.
Genetic testing identified 3 de novo heterozygous mutations in the sporadic cases plus one inherited heterozygous mutation in the familial case ( Figure 1A ). Patient 1 carries a missense mutation affecting a residue in the transmembrane domain segment 2 (NM_172108.3: c.388G>A; NP_742106.1: p.Glu130Lys; Figure 1B ). A maternal inherited variant, located in the transmembrane domain segment 5, was detected in Patient 2 (NM_172108.3: c.727C>T; NP_742106.1: p.Leu243Phe), whose pedigree shows a familial history of BFNS ( Figure 1A ). This variant was associated previously with BFNS. 20 In this patient, an aCGH study did not reveal pathogenic copy number variants (CNVs), whereas a further WES study did not detect pathogenic variants in genes related with either epilepsy or severe neurodevelopmental disorders. Figure 1A ). The latter 2 variants are located in the pore-forming segment of the resulting KCNQ2 protein ( Figure 1B ). All the variants found in these 4 patients affect residues highly conserved through all 5 Kv7 family members ( Figure 1C) , as well as among species ( Figure S2 ). The in silico predictor Mutation Taster classifies them as disease-causing mutations. Mutations L243F and E130K have been described in the ClinVar database associated with BFNS 1 phenotype (rs118192205) and EIEE 7 (rs864321710), respectively. None of the variants detected are found in the Exome Aggregation Consortium general population frequencies database (http://exac.broadinstitute.org).
| Functional characterization of Kv7.2 subunit carrying p.E130K, p.L243F, p.W270R, and p.G281R mutations
To study the consequences on channel function, macroscopic currents were recorded using the whole-cell configuration of the patch-clamp technique. HEK293T cells were transiently transfected with cDNAs encoding for Kv7.2 mutant subunits alone, or in combination with wildtype Kv7.2 or Kv7.3. Figure 2A shows a steady current flowing from cells expressing homomeric Kv7.2 channels held at −30 mV, reflecting the noninactivating properties of Kv7 channels. Current relaxations were evoked at different potentials, and the amplitude was measured as the difference of the instantaneous current on returning to −30 mV (tail current) after opening all channels by a preceding voltage step to +20 mV or +10 mV and closing all channels by jumping to −110 mV. The average current density in cells expressing homomeric Kv7.2 wild-type channels was 62.3 ± 8.8 pF/pA ( Figure 2E ); in contrast, the current was almost completely suppressed for the channels carrying the mutations E130K, W270R, and G281R, whereas some residual current was measured in cells expressing the subunit carrying the L243F mutation (8.0 ± 1.7 pF/pA, Figure 2A ,E). We next measured the current density when mutant channels were coexpressed with Kv7.2. This configuration revealed that E130K and G281R exerted a dominant-negative behavior, whereas current density was not affected by the presence of the L243F or W270R mutants. The ability of the different mutants to rescue the current when coexpressed with Kv7.3 was tested. Kv7.3 yields barely detectable currents when expressed alone in HEK293 cells. Compared to the density when Kv7.2 was expressed alone, a more than twofold increase was observed when coexpressed with Kv7.3 (Figures 2C,G) . The G281R mutant failed to rescue the current, whereas the current levels with W270R and L243F were about 40% of control. The current density observed with the E130K mutant was on average about 60% of control, but this reduction did not reach statistical significance. Functional consequences were also assessed in cells coexpressing Kv7.2 wt, Kv7.2 mutant, and Kv7.3 subunits at a 0.5:0.5:1.0 ratio to mimic the genetic balance. In this configuration, the current densities were indistinguishable from those in cells expressing the wild-type heteromeric configuration ( Figures 2D,H) . Figures 2I-K show the voltage-current relationship for the different configurations. The presence of the W270R mutation caused a left shift of the relationship when combined with Kv7.2 or Kv7.3. L243F presented a similar shift when combined with Kv7.3, whereas E130K resulted in a right shift under this configuration. However, these shifts disappeared when coexpressed with both Kv7.2 and Kv7.3 ( Figure 2K ). A summary of the biophysical properties of the subunit combinations is presented in Table 2 .
Because PIP 2 is an absolute requirement for Kv7 channel function, we sought to determine how these mutations affected this dependency. To answer this question, we used the DrVSP, which catalyzes the removal of a phosphate group at position 5, resulting in the rapid reduction of PIP 2 in the plasma membrane. DrVSP is barely active at the voltages used to quantify Kv7 current relaxations, 16 but becomes active at highly depolarized voltages. Thus, after a brief activation of DrVSP with a pulse to +100 mV, a subsequent voltage jumps to −110 mV from a holding voltage of −20 mV, resulted in smaller current relaxations. Thus, quantification of the size of these relaxations gives an assessment of the PIP 2 dependency. A summary of the impact of the mutations in PIP 2 dependency in different configurations is shown in Figure 3 . The sensitivity to PIP 2 depletion was increased when the mutant subunits were combined with W270R (Figure 3 ).
| DISCUSSION
Given the rarity of KCNQ2-related disorders and the interand intrafamilial phenotypic variability, channel functionphenotype correlations are difficult to establish. Finding a common functional consequence of KCNQ2 mutations may provide clues to the underlying mechanism in EIEE 7. 8 suggesting that E130K may affect these electrostatic interactions. The fact that the current density of the heteromeric mutant E130K/Kv7.3 is about 60% of control means that the dominant-negative impact of this mutation is partial. In contrast to the more severe phenotype observed for the G281R mutant, this patient had moderate motor and cognitive impairment.
6,11
The 2 remaining mutants (L243F and W270R) have some properties in common. None of them presented a marked dominant-negative impact, both rescued Kv7.3 to a similar extent, led to similar current densities when combined with Kv7.3 and Kv7.2, and caused a left shift in the current-voltage relationship when expressed with Kv7.3. However, the severity of the phenotype was different. The L243F mutation, described previously in an infant with relatively mild BFNS with favorable prognosis, 20 is described here in a patient with cognitive delay and autism spectrum disorder. The manifestation of this severe phenotype is not inherent to the functional consequences of the mutation, as evidenced by the mild symptoms described previously, 20 or the family members carrying the mutation with a benign phenotype. Similarly, within a BFNS family with 4 affected members carrying the K526N mutation, 2 presented encephalopathy, suggesting that other factors influence the phenotypic severity. 25 The phenotype for L243F is not apparently due to structural variants or exonic changes in any other gene associated previously with the EIEE phenotype. Variable expressivity of the KCNQ2 mutation remains a possibility in this pedigree, with intronic variants in regulatory regions, gene modifiers, and environmental factors as putative underlying mechanisms. In this regard, Patient 2 carried the SCN9A p.K655R variant, which could have exerted a modifier effect. A similar mechanism for the same variant has been postulated in Dravet syndrome, 26 with it being found in Dravet patients with or without identified SCN1A mutations and in febrile seizures evolving into continuous spike wave activity or idiopathic generalized epilepsy. 23 An assumption is that since all the mutations studied led to encephalopathy, a common functional property will be impaired, and the extent of the deficiency may correlate with the severity of the phenotype. However, the functional impact of these mutations was diverse, except for the almost complete obliteration under the homomeric Kv7.2 configuration, in line with electrophysiologic characterization of other EIEE-causing mutations outside the voltage sensor. 14, [27] [28] [29] Several studies have highlighted the Asterisks indicate values significantly different versus respective controls **P < 0.01 and ***P < 0.001. Alteration in the equilibrium between inhibitory or excitatory circuits due to gene mutations that are not compensated by homeostatic mechanisms can lead to neurologic disorders. 31 An effect on the excitation/inhibition balance during a critical period of development may help explaining the counterintuitive observation that both gain and loss of Kv7.2 function can lead to developmental neurologic impairment. 13, 32 We should consider that expression of KCNQ2 precedes that of KCNQ3. 33 Moreover, recent mice models support the concept that KCNQ2 appears more important than KCNQ3 for cortical excitability during early developmental stages. 3 It seems reasonable to speculate that, during this period, the pruning and fine-tuning of connections and circuits will be critically sensitive to the activity of homomeric Kv7.2 M-channels. Indeed, observations in a mouse model that allows reducing M-channel activity support the Kv7.2 critical period hypothesis. Mice with reduced M-channel activity during early neonatal development exhibited disturbances in cognitive function in adulthood. Allowing the Mchannel to fully function temporally during development prevented the anatomic disorganization and severe effects otherwise seen. 22 The idea that the disruption of excitation/inhibition balance is central to disease development has received strong support recently. It has been shown that pharmacologic intervention to enhance inhibitory routes during the early postnatal period of brain development prevents encephalopathy in a mouse model expressing a dominant-negative variant of Kv7.2 subunits. 31 In summary, a dominant-negative effect in heteromeric Kv7.2/3 function is not strictly required to develop the most severe phenotypes in EIEE 7, while we draw attention to the potential critical role of Kv7.2 homomeric M-channels during development.
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